WAP
BNTX icon

Wealthcare Advisory Partners’s BioNTech BNTX Stock Holding History

Wealthcare Advisory Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,621
Closed -$211K – 879
2024
Q2 		$211K Hold
2,621
– – 0.01% 777
2024
Q1 		$242K Buy
+2,621
New +$251K 0.01% 728

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wealthcare Advisory Partners's BNTX Position: Q3 2024 in Review

Wealthcare Advisory Partners sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 2,621 shares — an estimated $211K sold.

Wealthcare Advisory Partners first reported a position in BNTX in Q1 2024 and held it in 2 quarters. The position peaked at $242K in Q1 2024. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Wealthcare Advisory Partners reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 2,621 BioNTech shares in Q3 2024, an estimated $211K.
  • Wealthcare Advisory Partners first reported a position in BioNTech in Q1 2024 and held it in 2 quarters.
  • Wealthcare Advisory Partners's BioNTech position peaked at $242K in Q1 2024.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2024, filed 4 Nov 2024.